Metra signs agreement with Beckman Coulter:
This article was originally published in Clinica
Executive Summary
Metra Biosystems has formed a cross-licensing agreement with Beckman Coulter for a US patent owned by the latter company. Metra can continue to develop and sell the Alkphase-B formation marker under Beckman's patents and in exchange, Beckman Coulter gains the rights to develop, commercialise and sell Metra's Pyrilinks-D test for use on its automated laboratory analyser, the Access immunoassay system. The Pyrilinks-D test is a method for assaying urine samples for levels of deoxypyrid inoline, a marker of bone resorption.